Earnings Summary: Biogen Q4
Biogen (NASDAQ:BIIB) announced its Q4 earnings on Friday, February 6, 2026 at 07:00 AM.
Here's a breakdown of the earnings report.
Earnings
Biogen beat estimated earnings by 22.84%, reporting an EPS of $1.99 versus an estimate of $1.62.
Revenue was down $176.00 million from the same period last year.
Overview of Past Earnings
The company beat on EPS by $0.92 in the last quarter, resulting in a 3.11% increase share price change the following day.
Here's a look at Biogen's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 3.89 | 3.91 | 2.52 | 3.35 |
| EPS Actual | 4.81 | 5.47 | 3.02 | 3.44 |
| Revenue Estimate | 2.34B | 2.32B | 2.23B | 2.40B |
| Revenue Actual | 2.53B | 2.65B | 2.43B | 2.46B |
To track all earnings releases for Biogen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Importance Rank:
1
Posted-In: BZI-RecapsEarnings
